Sioux Falls, SD — One of the large health systems serving our area has announced a trial aimed at helping sufferers of osteoarthritis.
According to Sanford Health officials, Sanford has announced a groundbreaking stem cell trial, expanding the use of adult-adipose-derived stem cells in the use of osteoarthritis across five joints.
They tell us that the clinical trial, called the ENDURE trial, is a first-of-its-kind study. Males and females, over the age of 18 with a diagnosis of osteoarthritis in the wrist, knee, ankle, shoulder, or hip are eligible to participate in the study, which is regulated through the Food and Drug Administration. The cells are tested for quality and safety prior to injection, says Sanford.
David A. Pearce, PhD, president of Sanford Research, Innovation and World Clinic says, “Sanford Health and our talented team of researchers have worked diligently to find a way to help heal our patients with joint pain. These patients aren’t able to do the kinds of everyday activities they love, whether it’s playing catch with their kids, golfing, or going for a bike ride. We want to help them get back to enjoying what matters most to them and cherishing every moment without pain interrupting their life.”
During the ENDURE trial, Sanford will collect data and patient-reported outcomes. They say that the FDA support means that Sanford is able to offer the expanded use of these stem cells while keeping patient safety the number one priority.
They tell us this trial is the first FDA-permitted trial that allows for stem cell treatment in five joints.
The study is currently open at Sanford Health in Sioux Falls, South Dakota.
For more information about the ENDURE trial, they tell us you can visit SanfordHealth.org keyword: ENDURE.
